相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis
Sandra Garces et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
Uma Mahadevan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab
Viviana Lora et al.
IMMUNOLOGIC RESEARCH (2013)
Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis
S. Fenix-Caballero et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2013)
The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial)
Robert Strohal et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2013)
Which Antipsoriatic Drug Has the Fastest Onset of Action?: Systematic Review on the Rapidity of the Onset of Action
Alexander Nast et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
Rosa Parisi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Incidence of Cardiovascular Disease in Individuals with Psoriasis: A Systematic Review and Meta-Analysis
Eleanor J. Samarasekera et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
Iain B. McInnes et al.
LANCET (2013)
Association Between Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis
Jashin J. Wu et al.
ARCHIVES OF DERMATOLOGY (2012)
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry
Fabiola Atzeni et al.
AUTOIMMUNITY REVIEWS (2012)
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study
Maria Esposito et al.
DERMATOLOGY (2012)
Drug Dosing Based on Weight and Body Surface Area: Mathematical Assumptions and Limitations in Obese Adults
Manjunath P. Pai
PHARMACOTHERAPY (2012)
Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150 000 pregnant women and expectant fathers
K. K. Viktil et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)
Patients with Psoriasis Have a Higher Prevalence of Parental Cardiovascular Disease
Paolo Gisondi et al.
DERMATOLOGY (2011)
Acute infusion reactions induced by monoclonal antibody therapy
Enrico Maggi et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2011)
Safety of infliximab use during pregnancy
Nada Djokanovic et al.
REPRODUCTIVE TOXICOLOGY (2011)
Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review
Alexandra M. G. Brunasso et al.
RHEUMATOLOGY (2011)
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
W. G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study
A. Jamnitski et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
No Evidence of Association Between Anti-Tumor Necrosis Factor Treatment and Mortality in Patients With Rheumatoid Arthritis Results From the British Society for Rheumatology Biologics Register
Mark Lunt et al.
ARTHRITIS AND RHEUMATISM (2010)
Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: Rationale for dosing recommendations
Mark Lebwohl et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Long-term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-α–Blocker Therapy
Pierre Lozeron et al.
ARCHIVES OF NEUROLOGY (2009)
Risk of Tuberculosis Is Higher With Anti-Tumor Necrosis Factor Monoclonal Antibody Therapy Than With Soluble Tumor Necrosis Factor Receptor Therapy The Three-Year Prospective French Research Axed on Tolerance of Biotherapies Registry
F. Tubach et al.
ARTHRITIS AND RHEUMATISM (2009)
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
Alice Gottlieb et al.
LANCET (2009)
Tumor necrosis factor-α antagonist use and heart failure in elderly patients with rheumatoid arthritis
Soko Setoguchi et al.
AMERICAN HEART JOURNAL (2008)
Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis
B. Strober et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi et al.
LANCET (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
Kim A. Papp et al.
LANCET (2008)
Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection
Juan J. Gomez-Reino et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Recent advances of TNF-α antagonists in rheumatoid arthritis and chronic heart failure
Shaker A. Mousa et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab
Angel M. Garcia Aparicio et al.
CLINICAL RHEUMATOLOGY (2007)
A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis
Angela Moore et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy
C. H. Roux et al.
RHEUMATOLOGY (2007)
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Efficacy and safety of etanercept in psoriasis/psoriatic arthritis - An updated review
Alberto Romero-Mate et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2007)
Case report: Evidence for transplacental transfer of maternally administered infliximab to the newborn
Eric A. Vasiliauskas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Etanercept for the treatment of psoriasis in the elderly
Militello Giuseppe et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis
Monali J. Bhosle et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2006)
Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy
KB Gordon et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2006)
The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis
BR Don et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2005)
Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL)
DL Mann et al.
CIRCULATION (2004)
Heart failure in rheumatoid arthritis: Rates, predictors, and the effect of anti-tumor necrosis factor therapy
F Wolfe et al.
AMERICAN JOURNAL OF MEDICINE (2004)
TNF and congestive heart failure:: Therapeutic possibilities
J Müller-Ehmsen et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2004)
Retrospective analysis of adverse drug reactions with infliximab in a department of rheumatology
C Cabou et al.
THERAPIE (2003)
分享论文
